KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Approved in Japan for Radically Unresectable or Metastatic Renal Cell CarcinomaBusiness Wire • 02/25/22
South Africa Authorizes Merck's COVID-19 Antiviral Pill, But Government Not Buying: ReutersBenzinga • 02/17/22
Merck Inks Oncology, Neurology Drug Discovery Pact With British Biotech, Curve TherapeuticsBenzinga • 02/16/22
Organon Acquires Contraceptive Products, Marvelon® and Mercilon®, in the People's Republic of China, including Hong Kong and Macau, and Agrees to Acquire these Products in VietnamBusiness Wire • 02/16/22
LYNPARZA® (olaparib) Plus Abiraterone Reduced Risk of Disease Progression or Death by 34% Versus Abiraterone in First-Line Metastatic Castration-Resistant Prostate Cancer, Regardless of Biomarker StatusBusiness Wire • 02/14/22